Cambridge, United Kingdom

Ronald Henry Jackson

USPTO Granted Patents = 13 

 

Average Co-Inventor Count = 11.5

ph-index = 9

Forward Citations = 1,416(Granted Patents)


Location History:

  • Cabridge, GB (2020)
  • Cambridge, GB (1999 - 2022)

Company Filing History:


Years Active: 1999-2022

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: The Innovations of Ronald Henry Jackson

Introduction

Ronald Henry Jackson is a prominent inventor based in Cambridge, GB. He has made significant contributions to the field of metabolic disease treatment, particularly in obesity. With a total of 13 patents to his name, Jackson's work has had a considerable impact on medical research and therapeutic development.

Latest Patents

Among his latest patents, Jackson has developed glucagon/GLP-1 agonists for the treatment of obesity. This disclosure provides GLP-1/glucagon agonist peptides aimed at addressing metabolic diseases, such as obesity. His innovative approach in this area showcases his commitment to advancing medical science and improving patient outcomes.

Career Highlights

Throughout his career, Jackson has worked with esteemed organizations, including the Medical Research Council and MedImmune Limited. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Kevin Stuart Johnson and Gregory Paul Winter. Their collective expertise has fostered an environment of innovation and discovery in the realm of metabolic disease treatment.

Conclusion

Ronald Henry Jackson's contributions to the field of medical research, particularly in obesity treatment, highlight his role as a leading inventor. His patents and collaborations reflect a dedication to improving health outcomes through innovative solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…